Aravive, Inc. (ARAV) earnings
Quarterly and annual ARAV reports and results, each read against the price at its own news timestamp. Back to the ARAV overview →
1 measured ARAV earnings event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Aravive, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +6.54% |
Keep exploring
More ARAV: analyst actions → · SEC filings → · ARAV overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Remedent, Inc. (REMI) | 33 | 0.00% | 0% |
| AcelRx Pharmaceuticals, Inc. (ACRX) | 32 | +0.52% | 64% |
| Nemaura Medical, Inc. (NMRD) | 32 | 0.00% | 39% |
| Radius Recycling, Inc. - Class A (RDUS) | 32 | -0.14% | 38% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.